THU0119 Lack of effect of secukinumab treatment on the lipid profile in patients with rheumatoid arthritis: Results from a randomized, double-blind, placebo-controlled, phase II study

Abstract

BackgroundRheumatoid Arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease of unknown etiology characterized by symmetric synovitis leading to cartilage damage1. Chronic and severe RA is associated with a 50%...